159316 创新药E
已收盘 06-11 15:00:00
资讯
新帖
简况
创新药板块今日承压,关注港股通创新药ETF易方达(159316)中长期发展机遇
证券之星 · 19:20
创新药板块今日承压,关注港股通创新药ETF易方达(159316)中长期发展机遇
【ETF动向】6月10日创新药ETF银华基金涨1.69%,份额减少7200万份
证券之星 · 08:03
【ETF动向】6月10日创新药ETF银华基金涨1.69%,份额减少7200万份
医药板块逆势走强,基本面有望持续改善,关注港股通创新药ETF易方达(159316)配置价值
证券之星 · 06-10 19:04
医药板块逆势走强,基本面有望持续改善,关注港股通创新药ETF易方达(159316)配置价值
【ETF动向】6月9日港股通创新药ETF汇添富基金跌0.08%,份额减少3.02亿份
证券之星 · 06-10 08:02
【ETF动向】6月9日港股通创新药ETF汇添富基金跌0.08%,份额减少3.02亿份
港股创新药板块窄幅整理,关注港股通创新药ETF易方达(159316)配置价值
证券之星 · 06-09 18:28
港股创新药板块窄幅整理,关注港股通创新药ETF易方达(159316)配置价值
【ETF动向】6月8日港股通创新药ETF汇添富基金跌2.8%,份额减少6700万份
证券之星 · 06-09 08:02
【ETF动向】6月8日港股通创新药ETF汇添富基金跌2.8%,份额减少6700万份
【ETF动向】6月8日创新药ETF银华基金跌2.35%,份额增加1.39亿份
证券之星 · 06-09 07:31
【ETF动向】6月8日创新药ETF银华基金跌2.35%,份额增加1.39亿份
【ETF动向】6月4日创新药ETF银华基金跌1.23%,份额减少8340万份
证券之星 · 06-05
【ETF动向】6月4日创新药ETF银华基金跌1.23%,份额减少8340万份
【ETF动向】6月4日港股通创新药ETF汇添富基金跌0.55%,份额减少3.12亿份
证券之星 · 06-05
【ETF动向】6月4日港股通创新药ETF汇添富基金跌0.55%,份额减少3.12亿份
【ETF动向】6月3日创新药ETF银华基金跌1.74%,份额增加1.15亿份
证券之星 · 06-04
【ETF动向】6月3日创新药ETF银华基金跌1.74%,份额增加1.15亿份
【ETF动向】6月3日港股通创新药ETF汇添富基金跌3.48%,份额减少2.3亿份
证券之星 · 06-04
【ETF动向】6月3日港股通创新药ETF汇添富基金跌3.48%,份额减少2.3亿份
【ETF动向】6月2日创新药ETF银华基金跌1.45%,份额增加1.85亿份
证券之星 · 06-03
【ETF动向】6月2日创新药ETF银华基金跌1.45%,份额增加1.85亿份
【ETF动向】6月2日港股通创新药ETF汇添富基金跌2.43%,份额增加8300万份
证券之星 · 06-03
【ETF动向】6月2日港股通创新药ETF汇添富基金跌2.43%,份额增加8300万份
【ETF动向】6月1日创新药ETF银华基金跌1.3%,份额增加5.08亿份
证券之星 · 06-02
【ETF动向】6月1日创新药ETF银华基金跌1.3%,份额增加5.08亿份
【ETF动向】6月1日港股通创新药ETF汇添富基金跌1.81%,份额增加1.64亿份
证券之星 · 06-02
【ETF动向】6月1日港股通创新药ETF汇添富基金跌1.81%,份额增加1.64亿份
创新药行情拐点出现?重磅BD叠加ASCO催化,华宝基金港股通创新药ETF(520880)放量摸高4.29%!
新浪基金 · 05-31
创新药行情拐点出现?重磅BD叠加ASCO催化,华宝基金港股通创新药ETF(520880)放量摸高4.29%!
ETF日报(05.29)丨创新药ETF震荡反弹 科创50ETF集体重挫
智通财经网 · 05-29
ETF日报(05.29)丨创新药ETF震荡反弹 科创50ETF集体重挫
医药板块早盘逆势上涨,港股通创新药ETF易方达(159316)标的指数涨超3%
证券之星 · 05-29
医药板块早盘逆势上涨,港股通创新药ETF易方达(159316)标的指数涨超3%
【ETF动向】5月28日港股通创新药ETF汇添富基金跌4.14%,份额减少4.51亿份
中金财经 · 05-29
【ETF动向】5月28日港股通创新药ETF汇添富基金跌4.14%,份额减少4.51亿份
【ETF动向】5月28日创新药ETF银华基金跌2.22%,份额减少1.06亿份
证券之星 · 05-29
【ETF动向】5月28日创新药ETF银华基金跌2.22%,份额减少1.06亿份
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159316","market":"SZ","secType":"STK","nameCN":"创新药E","latestPrice":0.973,"timestamp":1781161437000,"preClose":0.984,"halted":0,"volume":833891400,"delay":0,"changeRate":-0.0112,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.011,"latestTime":"06-11 15:00:00","open":0.981,"high":0.988,"low":0.958,"amount":809000000,"amplitude":0.0305,"askPrice":0.973,"askSize":1519,"bidPrice":0.972,"bidSize":4945,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781227800000},"marketStatusCode":5,"adr":0,"adjPreClose":0.984,"symbolType":"fund","openAndCloseTimeList":[[1781141400000,1781148600000],[1781154000000,1781161200000]],"highLimit":1.082,"lowLimit":0.886,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":0.097802,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159316/wiki","defaultTab":"wiki","newsList":[{"id":"2642891712","title":"创新药板块今日承压,关注港股通创新药ETF易方达(159316)中长期发展机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2642891712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642891712?lang=zh_cn&edition=full","pubTime":"2026-06-11 19:20","pubTimestamp":1781176857,"startTime":"0","endTime":"0","summary":"6月11日,医药板块走势分化,创新药方向有所承压,截至收盘,恒生港股通创新药指数下跌1.1%,中证港股通医药卫生综合指数下跌1.0%,中证创新药产业指数下跌0.5%,中证生物科技主题指数下跌0.7%,沪深300医药卫生指数上涨0.1%。有分析认为,尽管短期市场情绪波动使得创新药板块承压,但从产业生态来看,审批通道的成熟、支付体系的完善以及管线临床数据的持续兑现,构成了创新药赛道中长期发展的坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026061100033085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159316","06978","BK1161","516080","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642728584","title":"【ETF动向】6月10日创新药ETF银华基金涨1.69%,份额减少7200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642728584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642728584?lang=zh_cn&edition=full","pubTime":"2026-06-11 08:03","pubTimestamp":1781136234,"startTime":"0","endTime":"0","summary":"证券之星消息,6月10日,创新药ETF银华基金(159992)涨1.69%,成交额5.34亿元。当日份额减少了7200万份,最新份额为192.16亿份,近20个交易日份额增加1.34亿份。当日资金净流入1.93亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为138.76亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.02%,近一个月超额回报为0.59%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100003908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428491","title":"医药板块逆势走强,基本面有望持续改善,关注港股通创新药ETF易方达(159316)配置价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428491?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:04","pubTimestamp":1781089491,"startTime":"0","endTime":"0","summary":"6月10日,医药板块主要指数逆势上涨,截至收盘,恒生港股通创新药指数上涨2.0%,中证港股通医药卫生综合指数上涨1.5%,中证创新药产业指数上涨1.8%,中证生物科技主题指数上涨1.0%,沪深300医药卫生指数上涨1.6%。从估值维度看,经过这一轮调整,港股创新药板块估值已有所回落,沪深300医药指数也处于近10年历史较低分位。此外,A股创新药板块一季度收入同比增长26.4%,多家生物科技公司已实现扭亏为盈,基本面有望持续改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026061000035676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159316","09939","159938","516080","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415311","title":"【ETF动向】6月9日港股通创新药ETF汇添富基金跌0.08%,份额减少3.02亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642415311?lang=zh_cn&edition=full","pubTime":"2026-06-10 08:02","pubTimestamp":1781049767,"startTime":"0","endTime":"0","summary":"证券之星消息,6月9日,港股通创新药ETF汇添富基金(159570)跌0.08%,成交额22.45亿元。当日份额减少了3.02亿份,最新份额为162.13亿份,近20个交易日份额减少33.3亿份。当日资金净流出5.83亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为197.63亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.3%,近一个月超额回报为0.11%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000006471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642461186","title":"港股创新药板块窄幅整理,关注港股通创新药ETF易方达(159316)配置价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2642461186","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642461186?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:28","pubTimestamp":1781000913,"startTime":"0","endTime":"0","summary":"截至收盘,恒生港股通创新药指数下跌0.9%,中证港股通医药卫生综合指数下跌1.0%,中证创新药产业指数上涨0.3%,中证生物科技主题指数下跌0.1%,沪深300医药卫生指数下跌0.5%。有分析认为,港股创新药板块汇聚了一批具有全球化临床能力和差异化管线的生物科技企业,随着海外临床数据持续读出和BD交易不断落地,板块中长期价值受到市场关注。当前恒生港股通创新药指数估值处于历史中低位区间,产业基本面正在改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026060900030046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["516080","159992","BK1574","159316","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642430924","title":"【ETF动向】6月8日港股通创新药ETF汇添富基金跌2.8%,份额减少6700万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642430924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642430924?lang=zh_cn&edition=full","pubTime":"2026-06-09 08:02","pubTimestamp":1780963366,"startTime":"0","endTime":"0","summary":"证券之星消息,6月8日,港股通创新药ETF汇添富基金(159570)跌2.8%,成交额17.99亿元。当日份额减少了6700万份,最新份额为165.15亿份,近20个交易日份额减少30.26亿份。当日资金净流出5.82亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为203.46亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.16%,近一个月超额回报为0.22%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900004876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642437080","title":"【ETF动向】6月8日创新药ETF银华基金跌2.35%,份额增加1.39亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642437080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642437080?lang=zh_cn&edition=full","pubTime":"2026-06-09 07:31","pubTimestamp":1780961474,"startTime":"0","endTime":"0","summary":"证券之星消息,6月8日,创新药ETF银华基金(159992)跌2.35%,成交额6.61亿元。当日份额增加了1.39亿份,最新份额为192.4亿份,近20个交易日份额增加7.91亿份。当日资金净流出2.31亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为136.06亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-5.96%,近一个月超额回报为0.51%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900004386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641193540","title":"【ETF动向】6月4日创新药ETF银华基金跌1.23%,份额减少8340万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641193540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641193540?lang=zh_cn&edition=full","pubTime":"2026-06-05 08:03","pubTimestamp":1780617833,"startTime":"0","endTime":"0","summary":"证券之星消息,6月4日,创新药ETF银华基金(159992)跌1.23%,成交额4.83亿元。当日份额减少了8340万份,最新份额为191.94亿份,近20个交易日份额增加8.69亿份。当日资金净流出2.13亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为139.02亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.14%,近一个月超额回报为0.5%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500004664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641919359","title":"【ETF动向】6月4日港股通创新药ETF汇添富基金跌0.55%,份额减少3.12亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641919359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641919359?lang=zh_cn&edition=full","pubTime":"2026-06-05 08:02","pubTimestamp":1780617742,"startTime":"0","endTime":"0","summary":"证券之星消息,6月4日,港股通创新药ETF汇添富基金(159570)跌0.55%,成交额24.69亿元。当日份额减少了3.12亿份,最新份额为166.84亿份,近20个交易日份额减少28.07亿份。当日资金净流出6.75亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为213.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.36%,近一个月超额回报为1.27%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500004335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640277180","title":"【ETF动向】6月3日创新药ETF银华基金跌1.74%,份额增加1.15亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640277180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640277180?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:04","pubTimestamp":1780531440,"startTime":"0","endTime":"0","summary":"证券之星消息,6月3日,创新药ETF银华基金(159992)跌1.74%,成交额5.58亿元。当日份额增加了1.15亿份,最新份额为192.77亿份,近20个交易日份额增加9.31亿份。当日资金净流出1.65亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为141.15亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.21%,近一个月超额回报为0.5%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400003901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640804041","title":"【ETF动向】6月3日港股通创新药ETF汇添富基金跌3.48%,份额减少2.3亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640804041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640804041?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:02","pubTimestamp":1780531348,"startTime":"0","endTime":"0","summary":"证券之星消息,6月3日,港股通创新药ETF汇添富基金(159570)跌3.48%,成交额29.52亿元。当日份额减少了2.3亿份,最新份额为169.96亿份,近20个交易日份额减少25.01亿份。当日资金净流出8.48亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为220.5亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.48%,近一个月超额回报为1.24%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400003574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640492404","title":"【ETF动向】6月2日创新药ETF银华基金跌1.45%,份额增加1.85亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640492404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640492404?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:32","pubTimestamp":1780446764,"startTime":"0","endTime":"0","summary":"证券之星消息,6月2日,创新药ETF银华基金(159992)跌1.45%,成交额5.71亿元。当日份额增加了1.85亿份,最新份额为191.63亿份,近20个交易日份额增加9.63亿份。当日资金净流出8243.16万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为142.8亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.33%,近一个月超额回报为0.49%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300009360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640924085","title":"【ETF动向】6月2日港股通创新药ETF汇添富基金跌2.43%,份额增加8300万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640924085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640924085?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:31","pubTimestamp":1780446704,"startTime":"0","endTime":"0","summary":"证券之星消息,6月2日,港股通创新药ETF汇添富基金(159570)跌2.43%,成交额19.19亿元。当日份额增加了8300万份,最新份额为172.26亿份,近20个交易日份额减少22.9亿份。当日资金净流出5.27亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为228.98亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.62%,近一个月超额回报为1.24%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300009030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640993130","title":"【ETF动向】6月1日创新药ETF银华基金跌1.3%,份额增加5.08亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640993130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640993130?lang=zh_cn&edition=full","pubTime":"2026-06-02 08:32","pubTimestamp":1780360353,"startTime":"0","endTime":"0","summary":"证券之星消息,6月1日,创新药ETF银华基金(159992)跌1.3%,成交额8.77亿元。当日份额增加了5.08亿份,最新份额为189.78亿份,近20个交易日份额增加7.34亿份。当日资金净流入2.29亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为143.63亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.44%,近一个月超额回报为0.49%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200007844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640993939","title":"【ETF动向】6月1日港股通创新药ETF汇添富基金跌1.81%,份额增加1.64亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640993939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640993939?lang=zh_cn&edition=full","pubTime":"2026-06-02 08:31","pubTimestamp":1780360305,"startTime":"0","endTime":"0","summary":"证券之星消息,6月1日,港股通创新药ETF汇添富基金(159570)跌1.81%,成交额36.21亿元。当日份额增加了1.64亿份,最新份额为171.43亿份,近20个交易日份额减少23.73亿份。当日资金净流出1.85亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为234.25亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.87%,近一个月超额回报为1.18%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200007525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639888099","title":"创新药行情拐点出现?重磅BD叠加ASCO催化,华宝基金港股通创新药ETF(520880)放量摸高4.29%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2639888099","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639888099?lang=zh_cn&edition=full","pubTime":"2026-05-31 19:37","pubTimestamp":1780227420,"startTime":"0","endTime":"0","summary":"5月最后一个交易日,AH创新药联手反击,重仓A股创新药的药ETF华宝、满仓港药的港股通创新药ETF华宝午前启动,午后携手冲高,分别收涨2.35%、3.57%,大幅跑赢市场。 聚焦港股通创新药板块,百亿美元大单加持,信达生物率先领跑,一度狂飙近13%,午后康方生物、石药集团、三生制药等权重龙头集体跟进,带动100%创新药研发标的——港股通创新药ETF华宝冲高4.29%!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-05-31/doc-inhzuvri9145078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK1574","520880","VXUS","06978","159992","159316","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639628423","title":"ETF日报(05.29)丨创新药ETF震荡反弹 科创50ETF集体重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2639628423","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639628423?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:26","pubTimestamp":1780043177,"startTime":"0","endTime":"0","summary":"今日港股大盘温和上涨,尾盘恒科指翻绿。ASCO大会开幕在即叠加国产BD加速出海,创新药ETF震荡反弹;芯片产业链回落,科创50ETF集体重挫。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260529/20260529163118_28241.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260529/20260529163118_28241.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4550","159681","159316","FDN","588380","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639264995","title":"医药板块早盘逆势上涨,港股通创新药ETF易方达(159316)标的指数涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639264995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639264995?lang=zh_cn&edition=full","pubTime":"2026-05-29 13:12","pubTimestamp":1780031559,"startTime":"0","endTime":"0","summary":"截至午间收盘,恒生港股通创新药指数上涨3.5%,中证港股通医药卫生综合指数上涨3.2%,中证创新药产业指数上涨1.5%,中证生物科技主题指数上涨1.2%,沪深300医药卫生指数上涨2.0%。机构认为,港股医药板块此轮调整主要受资金与交易因素影响,行业基本面并未出现系统性走弱。目前处于年报收官、重磅医学会议来临前的催化空窗期,板块短期缺少事件驱动。后续产业利好将陆续释放,5月底至6月举办的ASCO大会,也将成为创新药、CXO产业链的重要看点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026052900021528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["516080","159938","BK1161","BK1515","BK1574","09939","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639024612","title":"【ETF动向】5月28日港股通创新药ETF汇添富基金跌4.14%,份额减少4.51亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2639024612","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639024612?lang=zh_cn&edition=full","pubTime":"2026-05-29 08:13","pubTimestamp":1780013607,"startTime":"0","endTime":"0","summary":"证券之星消息,5月28日,港股通创新药ETF汇添富基金(159570)跌4.14%,成交额26.82亿元。当日份额减少了4.51亿份,最新份额为174.24亿份,近20个交易日份额减少18.8亿份。当日资金净流出17.14亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为232亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-3.55%,近一个月超额回报为1.33%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260529/32263425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["FDN","159316","BK4550","BK4588","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639122696","title":"【ETF动向】5月28日创新药ETF银华基金跌2.22%,份额减少1.06亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2639122696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639122696?lang=zh_cn&edition=full","pubTime":"2026-05-29 08:04","pubTimestamp":1780013047,"startTime":"0","endTime":"0","summary":"证券之星消息,5月28日,创新药ETF银华基金(159992)跌2.22%,成交额6.99亿元。当日份额减少了1.06亿份,最新份额为186.7亿份,近20个交易日份额增加3.18亿份。当日资金净流出3.98亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为139.8亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.62%,近一个月超额回报为0.21%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900007544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781189747820,"stockEarnings":[{"period":"1week","weight":-0.0409},{"period":"1month","weight":-0.209},{"period":"3month","weight":-0.1861},{"period":"6month","weight":-0.2828},{"period":"1year","weight":-0.2442},{"period":"ytd","weight":-0.2172}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0549},{"period":"3month","weight":-0.0329},{"period":"6month","weight":0.0267},{"period":"1year","weight":0.1797},{"period":"ytd","weight":0.0061}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药E,159316,创新药E股票,创新药E股票老虎,创新药E股票老虎国际,创新药E行情,创新药E股票行情,创新药E股价,创新药E股市,创新药E股票价格,创新药E股票交易,创新药E股票购买,创新药E股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}